Learn About Research
Study opportunities are shared only when appropriate approvals, study materials, and site workflows are ready.
Patients and families
Understand research before sharing medical details.
Plain-language study education, privacy guidance, visit expectations, support options, and a general information request pathway.
For patients, families, and community members.
Clinical research participation is explained clearly, reviewed carefully, and handled through approved study processes.
Understand Your Choice
Participation is voluntary. Each study explains purpose, risks, benefits, visits, privacy, and alternatives before consent.
Protect Your Privacy
Protected details belong in secure study workflows, while general email remains reserved for basic questions.
Support Around Visits
Medisana may help coordinate transportation, reminders, and HHA-supported patient services when available, appropriate, and allowed by the study.
Currently enrolling studies
Approved openings will appear here when studies are ready for public outreach.
Medisana will list sponsor- or IRB-approved study summaries only after the required materials, privacy routing, and participant-facing language are ready.
When a study opens, this area can show the condition area, basic age range, visit location, transportation availability, and how to request secure prescreening.
Request study updatesPublic summaries stay high level, with protected details reserved for the secure research portal.
Patient education video
NIMH: What is Clinical Research?
View NIMH participant resources
Clinical research helps advance care by answering questions carefully, with trained teams, approved plans, and participant safety checks built into the process.
Open the video directlyView NIMH participant resources
During an approved study
What participants can expect after a study is open.
-
Pre-screening and eligibility
The study team reviews basic criteria and answers questions before any research decision is made.
-
Informed consent
The visit explains purpose, risks, benefits, privacy, time commitment, alternatives, and the voluntary nature of participation.
-
Study visits and assessments
Approved protocol visits may include exams, questionnaires, labs, diagnostics, medication dispensing, or follow-up check-ins.
-
Visit support when available
Transportation coordination, reminders, and HHA-supported services may help reduce participation burden when appropriate and study-allowed.
-
Safety monitoring
The principal investigator and study team monitor safety, document concerns, and coordinate with the sponsor, CRO, and IRB when required.
-
Completion or withdrawal
Participants may complete scheduled visits or choose to leave the study, with guidance on how to stop safely.
Study participant pathway
Request information now. Complete secure prescreening only when a study is ready.
Patients and families can ask to be contacted about future approved study opportunities. Detailed medical prescreening is handled through the secure research portal after privacy, consent, access control, and IRB or sponsor-approved materials are in place.
Demographic profile
Age range, sex at birth, race, ethnicity, preferred language, location, and contact preferences when needed for a specific study.
Current and past medical conditions
Study-specific condition history, diagnosis timing, relevant procedures, and inclusion or exclusion criteria.
Medication and treatment list
Current medications, recent medication changes, allergies, prior therapies, and pharmacy-related requirements.
Study fit and safety review
Research staff review responses under the approved protocol before scheduling screening, consent, or study visits.
Detailed medical questionnaires are reserved for the secure research portal once HIPAA safeguards, role-based access, consent language, and study-specific approvals are active.